- Article
Pseudolaric Acid B Targets CD147 to Selectively Kill Acute Myeloid Leukemia Cells
- Sheng Zou,
- Ekaterina Parfenova,
- Nikolina Vrdoljak,
- Mark D. Minden and
- Paul A. Spagnuolo
Acute myeloid leukemia (AML) is an aggressive blood cancer. With low survival rates, new drug targets are needed to improve treatment regimens and patient outcomes. Pseudolaric acid B (PAB) is a plant-derived bioactive compound predicted to interact...